BayHelix and Elsevier Announce Four China Drug Development Awards
publication date: Sep 26, 2012
To honor innovative drug development in China, the BayHelix Group and Elsevier Business Intelligence selected four companies and individuals for the 2012 BayHelix-Elsevier Awards, recognizing significant achievements in four different areas of pharmaceutical development. The winners were: Professor Ningshao Xia and his team at Xiamen University for the first Hepatitis E vaccine; the Hutchison MediPharma/Astra Zeneca cancer drug partnership; ZheJiang BetaPharma’s launch of its cancer drug and its innovative pricing plan; and Steve Yang of Lilly for his international leadership. More details....
Stock Symbol: (NYSE: LLY)
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.